
|Poll|January 27, 2023
Poll: How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Author(s)OT Staff Reports
Let us know how familiar are you on the approval process for biosimilar drugs compared with new drug applications to the FDA. The poll will be open until February 28, 2023.
Advertisement
How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR and Broadwood conflict over proposed Alcon merger continues
2
FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy
3
Finding your fit: Excimer lasers and early surgical practice
4
Ocular surface: Targeted therapies for a multifactorial problem
5